Journal
THORACIC CANCER
Volume 2, Issue 4, Pages 143-148Publisher
WILEY
DOI: 10.1111/j.1759-7714.2011.00064.x
Keywords
Astrocyte elevated gene 1; chemoresistance; metastasis; metadherin; multifunctional gene; tumor progression
Categories
Funding
- National Natural Science Foundation of China [81071754]
- Chinese Academy of Sciences [KSCX2-YW-R-192, 2009OHTP08]
- Shanghai Pujiang Program [10PJ1411600]
Ask authors/readers for more resources
We and others recently identified the gene metadherin (MTDH) as a functional driver in multiple aspects of cancer progression. It is overexpressed in cancer cells originating from a variety of tissues, partially due to DNA amplification of the chromosomal 8q22 region where this gene resides. The rapidly accumulated data from MTDH studies of the past several years have documented its role in tumorigenesis, angiogenesis, cell proliferation, survival, anchorage-independent growth, metastasis and chemoresistance. In particular, it simultaneously helps the primary tumor cells to survive conventional chemotherapy and spread to distant organs, both of which are major contributors to cancer therapy failure and ultimately patient death. The efforts to elucidate the molecular mechanism of MTDH functions led to observations indicating its involvement in several prominent cancer-related signaling pathways including Ras, c-Myc, PI3K/AKT, NF-?B, Wnt/beta-catenin, and more recently, microRNA machinery. Herein we will briefly summarize the studies that establish MTDH as a promising target for cancer therapeutics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available